These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 32571749)

  • 41. Quantitative hepatitis B surface antigen levels in patients with chronic hepatitis B after 2 years of entecavir treatment.
    Fung J; Lai CL; Young J; Wong DK; Yuen J; Seto WK; Yuen MF
    Am J Gastroenterol; 2011 Oct; 106(10):1766-73. PubMed ID: 21826112
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A large population study of spontaneous HBeAg seroconversion and acute exacerbation of chronic hepatitis B infection: implications for antiviral therapy.
    Yuen MF; Yuan HJ; Hui CK; Wong DK; Wong WM; Chan AO; Wong BC; Lai CL
    Gut; 2003 Mar; 52(3):416-9. PubMed ID: 12584226
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Durability of HBeAg seroconversion following antiviral therapy for chronic hepatitis B: relation to type of therapy and pretreatment serum hepatitis B virus DNA and alanine aminotransferase.
    van Nunen AB; Hansen BE; Suh DJ; Löhr HF; Chemello L; Fontaine H; Heathcote J; Song BC; Janssen HL; de Man RA; Schalm SW
    Gut; 2003 Mar; 52(3):420-4. PubMed ID: 12584227
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Three years of continuous entecavir therapy in treatment-naïve chronic hepatitis B patients: VIRAL suppression, viral resistance, and clinical safety.
    Yuen MF; Seto WK; Fung J; Wong DK; Yuen JC; Lai CL
    Am J Gastroenterol; 2011 Jul; 106(7):1264-71. PubMed ID: 21364549
    [TBL] [Abstract][Full Text] [Related]  

  • 45. An extended two-year trial of lamivudine in Chinese patients with chronic hepatitis B.
    Yao G; Cui Z; Wang B; Yao J; Zeng M
    Chin Med J (Engl); 2002 Dec; 115(12):1814-8. PubMed ID: 12622930
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pretherapy alanine transaminase level as a determinant for hepatitis B e antigen seroconversion during lamivudine therapy in patients with chronic hepatitis B. Asian Hepatitis Lamivudine Trial Group.
    Chien RN; Liaw YF; Atkins M
    Hepatology; 1999 Sep; 30(3):770-4. PubMed ID: 10462384
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Management of hepatitis B in China.
    Yao GB
    J Med Virol; 2000 Jul; 61(3):392-7. PubMed ID: 10861652
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Efficacy of granulocyte-macrophage colony-stimulating factor or lamivudine combination with recombinant interferon in non-responders to interferon in hepatitis B virus-related chronic liver disease patients.
    Guptan RC; Thakur V; Kazim SN; Sarin SK
    J Gastroenterol Hepatol; 2002 Jul; 17(7):765-71. PubMed ID: 12121506
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hepatitis B surface antigen loss and sustained viral suppression in Asian chronic hepatitis B patients: A community-based real-world study.
    Wong RJ; Nguyen MT; Trinh HN; Chan C; Huynh A; Ly MT; Nguyen HA; Nguyen KK; Torres S; Yang J; Liu B; Garcia RT; Bhuket T; Baden R; Levitt B; da Silveira E; Gish RG
    J Viral Hepat; 2017 Dec; 24(12):1089-1097. PubMed ID: 28581644
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The prognosis and management of inactive HBV carriers.
    Invernizzi F; Viganò M; Grossi G; Lampertico P
    Liver Int; 2016 Jan; 36 Suppl 1():100-4. PubMed ID: 26725905
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lamivudine therapy for children with chronic hepatitis B.
    Liberek A; Szaflarska-Popławska A; Korzon M; Łuczak G; Góra-Gebka M; Łoś-Rycharska E; Bako W; Czerwionka-Szaflarska M
    World J Gastroenterol; 2006 Apr; 12(15):2412-6. PubMed ID: 16688835
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Correlation of HBcrAg with Intrahepatic Hepatitis B Virus Total DNA and Covalently Closed Circular DNA in HBeAg-Positive Chronic Hepatitis B Patients.
    Wang L; Cao X; Wang Z; Gao Y; Deng J; Liu X; Zhuang H
    J Clin Microbiol; 2019 Jan; 57(1):. PubMed ID: 30355757
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hepatitis B virus DNA prediction rules for hepatitis B e antigen-negative chronic hepatitis B.
    Feld JJ; Ayers M; El-Ashry D; Mazzulli T; Tellier R; Heathcote EJ
    Hepatology; 2007 Oct; 46(4):1057-70. PubMed ID: 17654702
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A comparison of telbivudine and entecavir for chronic hepatitis B in real-world clinical practice.
    Tsai MC; Lee CM; Chiu KW; Hung CH; Tung WC; Chen CH; Tseng PL; Chang KC; Wang JH; Lu SN; Yen YH; Hu TH
    J Antimicrob Chemother; 2012 Mar; 67(3):696-9. PubMed ID: 22174039
    [TBL] [Abstract][Full Text] [Related]  

  • 55. qHBsAg for the Identification of Liver Histological Abnormalities in HBeAg-Negative Chronic Hepatitis B Patients with Normal and Mildly Elevated ALT Levels.
    Gan Q; Huang Y; Zhu C; Zhao S; Fu H; Cai M; Wang J; Zhang C; Guo S; Cao Z; Xie Q
    Can J Gastroenterol Hepatol; 2022; 2022():8695196. PubMed ID: 35875362
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The importance of the serum quantitative levels of hepatitis B surface antigen and hepatitis B e antigen in children with chronic hepatitis B.
    Demirören K; Kocamaz H; Doğan Y
    Turk J Gastroenterol; 2015 Jan; 26(1):36-41. PubMed ID: 25698269
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficacy of entecavir with or without tenofovir disoproxil fumarate for nucleos(t)ide-naïve patients with chronic hepatitis B.
    Lok AS; Trinh H; Carosi G; Akarca US; Gadano A; Habersetzer F; Sievert W; Wong D; Lovegren M; Cohen D; Llamoso C
    Gastroenterology; 2012 Sep; 143(3):619-628.e1. PubMed ID: 22643350
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Relationship between hepatitis B virus DNA levels and liver histology in patients with chronic hepatitis B.
    Shao J; Wei L; Wang H; Sun Y; Zhang LF; Li J; Dong JQ
    World J Gastroenterol; 2007 Apr; 13(14):2104-7. PubMed ID: 17465456
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical and histopathological features of chronic hepatitis B virus infected patients with high HBV-DNA viral load and normal alanine aminotransferase level: A multicentre-based study in China.
    Xing YF; Zhou DQ; He JS; Wei CS; Zhong WC; Han ZY; Peng DT; Shao MM; Sham TT; Mok DK; Chan CO; Tong GD
    PLoS One; 2018; 13(9):e0203220. PubMed ID: 30180183
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Optimal timing of antiviral therapy for chronic HBV-infected patients with normal ALT].
    Gui HL; Xie Q
    Zhonghua Gan Zang Bing Za Zhi; 2020 Dec; 28(12):988-991. PubMed ID: 34865343
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.